Skip to main content
Erschienen in: Journal of Cancer Education 2/2021

26.10.2019

Healthcare Access, Utilization, and Preventive Health Behaviors by Eligibility for Lung Cancer Screening

verfasst von: Eric A. Miller, Paul F. Pinsky

Erschienen in: Journal of Cancer Education | Ausgabe 2/2021

Einloggen, um Zugang zu erhalten

Abstract

In 2013, the US Preventive Services Task Force recommended low-dose computed tomography screening for smokers at high risk of lung cancer; however, use remains low. Efforts to promote lung cancer screening need to consider how receptive this population is to preventive healthcare and cancer screening. In addition, because of demonstrated heterogeneity in behaviors by smoking status, interventions may need to differ among eligible high-risk subgroups. To assess the engagement of high-risk smokers in other preventive healthcare behaviors, we examined healthcare use, including non-lung cancer screening, and healthcare provider discussions regarding screening by eligibility for lung cancer screening. We used the 2015 National Health Interview Survey to assess smoking history, healthcare use, cancer screening, vaccinations, and healthcare provider discussions regarding non-lung cancer screening. We calculated weighted prevalence estimates and prevalence ratios comparing eligible and ineligible current and former smokers to never smokers. Eligible current and former smokers had significantly different healthcare utilization and screening concordance compared to never smokers and to each other. Compared to never smokers, eligible current smokers were significantly less likely to be concordant with breast, colorectal, and cervical cancer screening while eligible former smokers were only less likely to be concordant with breast cancer screening. Eligible current smokers were less likely to report physician discussions about non-lung screening tests. Provider discussions about screening and engagement in preventive healthcare differed among current and former smokers eligible for lung cancer screening. Intervention efforts to increase lung cancer screening levels will likely need to differ as well.
Literatur
1.
Zurück zum Zitat Aberle DR et al (2013) Results of the two incidence screenings in the National Lung Screening Trial. N Engl J Med 369(10):920–931CrossRef Aberle DR et al (2013) Results of the two incidence screenings in the National Lung Screening Trial. N Engl J Med 369(10):920–931CrossRef
2.
Zurück zum Zitat Humphrey LL, Deffebach M, Pappas M, Baumann C, Artis K, Mitchell JP, Zakher B, Fu R, Slatore CG (2013) Screening for lung cancer with low-dose computed tomography: a systematic review to update the US Preventive services task force recommendation. Ann Intern Med 159(6):411–420CrossRef Humphrey LL, Deffebach M, Pappas M, Baumann C, Artis K, Mitchell JP, Zakher B, Fu R, Slatore CG (2013) Screening for lung cancer with low-dose computed tomography: a systematic review to update the US Preventive services task force recommendation. Ann Intern Med 159(6):411–420CrossRef
3.
Zurück zum Zitat Jemal A, Fedewa SA (2017) Lung cancer screening with low-dose computed tomography in the United States-2010 to 2015. JAMA Oncol 3(9):1278–1281CrossRef Jemal A, Fedewa SA (2017) Lung cancer screening with low-dose computed tomography in the United States-2010 to 2015. JAMA Oncol 3(9):1278–1281CrossRef
4.
Zurück zum Zitat Mishra SI et al (2016) Patient perspectives on low-dose computed tomography for lung cancer screening, New Mexico, 2014. Prev Chronic Dis 13:E108CrossRef Mishra SI et al (2016) Patient perspectives on low-dose computed tomography for lung cancer screening, New Mexico, 2014. Prev Chronic Dis 13:E108CrossRef
5.
Zurück zum Zitat Gressard L, DeGroff A, Richards TB, Melillo S, Kish-Doto J, Heminger CL, Rohan EA, Allen KG (2017) A qualitative analysis of smokers' perceptions about lung cancer screening. BMC Public Health 17(1):589CrossRef Gressard L, DeGroff A, Richards TB, Melillo S, Kish-Doto J, Heminger CL, Rohan EA, Allen KG (2017) A qualitative analysis of smokers' perceptions about lung cancer screening. BMC Public Health 17(1):589CrossRef
6.
Zurück zum Zitat Vander Weg MW (2012) M.B. Howren, and X. Cai, Use of routine clinical preventive services among daily smokers, non-daily smokers, former smokers, and never-smokers. Nicotine Tob Res 14(2):123–130CrossRef Vander Weg MW (2012) M.B. Howren, and X. Cai, Use of routine clinical preventive services among daily smokers, non-daily smokers, former smokers, and never-smokers. Nicotine Tob Res 14(2):123–130CrossRef
7.
Zurück zum Zitat Bryan L, Westmaas L, Alcaraz K, Jemal A (2014) Cigarette smoking and cancer screening underutilization by state: BRFSS 2010. Nicotine Tob Res 16(9):1183–1189CrossRef Bryan L, Westmaas L, Alcaraz K, Jemal A (2014) Cigarette smoking and cancer screening underutilization by state: BRFSS 2010. Nicotine Tob Res 16(9):1183–1189CrossRef
8.
Zurück zum Zitat Jorm LR et al (2012) Smoking and use of primary care services: findings from a population-based cohort study linked with administrative claims data. BMC Health Serv Res 12:263CrossRef Jorm LR et al (2012) Smoking and use of primary care services: findings from a population-based cohort study linked with administrative claims data. BMC Health Serv Res 12:263CrossRef
9.
Zurück zum Zitat Moyer VA (2012) and U.S.P.S.T. Force, Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 157(2):120–134CrossRef Moyer VA (2012) and U.S.P.S.T. Force, Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 157(2):120–134CrossRef
10.
Zurück zum Zitat Moyer VA, U.S.P.S.T. Force (2012) Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 156(12):880–891 W312CrossRef Moyer VA, U.S.P.S.T. Force (2012) Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 156(12):880–891 W312CrossRef
11.
Zurück zum Zitat Moyer VA (2014) and U.S.P.S.T. Force, Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 160(5):330–338CrossRef Moyer VA (2014) and U.S.P.S.T. Force, Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 160(5):330–338CrossRef
12.
Zurück zum Zitat Nelson HD et al (2009) Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med 151(10):727–737 W237-42CrossRef Nelson HD et al (2009) Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med 151(10):727–737 W237-42CrossRef
13.
Zurück zum Zitat Force USPST et al (2016) Screening for colorectal cancer: US Preventive Services Task Force Recommendation Statement. JAMA 315(23):2564–2575CrossRef Force USPST et al (2016) Screening for colorectal cancer: US Preventive Services Task Force Recommendation Statement. JAMA 315(23):2564–2575CrossRef
14.
Zurück zum Zitat Berkowitz Z et al (2017) Patterns of prostate-specific antigen test use in the U.S., 2005-2015. Am J Prev Med 53(6):909–913CrossRef Berkowitz Z et al (2017) Patterns of prostate-specific antigen test use in the U.S., 2005-2015. Am J Prev Med 53(6):909–913CrossRef
15.
Zurück zum Zitat Jemal A, Fedewa SA, Ma J, Siegel R, Lin CC, Brawley O, Ward EM (2015) Prostate cancer incidence and PSA testing patterns in relation to USPSTF screening recommendations. JAMA 314(19):2054–2061CrossRef Jemal A, Fedewa SA, Ma J, Siegel R, Lin CC, Brawley O, Ward EM (2015) Prostate cancer incidence and PSA testing patterns in relation to USPSTF screening recommendations. JAMA 314(19):2054–2061CrossRef
16.
Zurück zum Zitat Bieler GS, Brown GG, Williams RL, Brogan DJ (2010) Estimating model-adjusted risks, risk differences, and risk ratios from complex survey data. Am J Epidemiol 171(5):618–623CrossRef Bieler GS, Brown GG, Williams RL, Brogan DJ (2010) Estimating model-adjusted risks, risk differences, and risk ratios from complex survey data. Am J Epidemiol 171(5):618–623CrossRef
17.
Zurück zum Zitat Byrne MM, Davila EP, Zhao W, Parker D, Hooper MW, Caban-Martinez A, Dietz N, Huang Y, Messiah A, Lee DJ (2010) Cancer screening behaviors among smokers and non-smokers. Cancer Epidemiol 34(5):611–617CrossRef Byrne MM, Davila EP, Zhao W, Parker D, Hooper MW, Caban-Martinez A, Dietz N, Huang Y, Messiah A, Lee DJ (2010) Cancer screening behaviors among smokers and non-smokers. Cancer Epidemiol 34(5):611–617CrossRef
18.
Zurück zum Zitat Chi RC, Reiber GE, Neuzil KM (2006) Influenza and pneumococcal vaccination in older veterans: results from the behavioral risk factor surveillance system. J Am Geriatr Soc 54(2):217–223CrossRef Chi RC, Reiber GE, Neuzil KM (2006) Influenza and pneumococcal vaccination in older veterans: results from the behavioral risk factor surveillance system. J Am Geriatr Soc 54(2):217–223CrossRef
19.
Zurück zum Zitat Quaife SL, McEwen A, Janes SM, Wardle J (2015) Smoking is associated with pessimistic and avoidant beliefs about cancer: results from the International Cancer Benchmarking Partnership. Br J Cancer 112(11):1799–1804CrossRef Quaife SL, McEwen A, Janes SM, Wardle J (2015) Smoking is associated with pessimistic and avoidant beliefs about cancer: results from the International Cancer Benchmarking Partnership. Br J Cancer 112(11):1799–1804CrossRef
20.
Zurück zum Zitat Arnett JJ (2000) Optimistic bias in adolescent and adult smokers and nonsmokers. Addict Behav 25(4):625–632CrossRef Arnett JJ (2000) Optimistic bias in adolescent and adult smokers and nonsmokers. Addict Behav 25(4):625–632CrossRef
21.
Zurück zum Zitat Chapman S, Wong WL, Smith W (1993) Self-exempting beliefs about smoking and health: differences between smokers and ex-smokers. Am J Public Health 83(2):215–219CrossRef Chapman S, Wong WL, Smith W (1993) Self-exempting beliefs about smoking and health: differences between smokers and ex-smokers. Am J Public Health 83(2):215–219CrossRef
22.
Zurück zum Zitat Almirall J, Bolíbar I, Balanzó X, González CA (1999) Risk factors for community-acquired pneumonia in adults: a population-based case-control study. Eur Respir J 13(2):349–355CrossRef Almirall J, Bolíbar I, Balanzó X, González CA (1999) Risk factors for community-acquired pneumonia in adults: a population-based case-control study. Eur Respir J 13(2):349–355CrossRef
23.
Zurück zum Zitat Jonnalagadda S, Bergamo C, Lin JJ, Lurslurchachai L, Diefenbach M, Smith C, Nelson JE, Wisnivesky JP (2012) Beliefs and attitudes about lung cancer screening among smokers. Lung Cancer 77(3):526–531CrossRef Jonnalagadda S, Bergamo C, Lin JJ, Lurslurchachai L, Diefenbach M, Smith C, Nelson JE, Wisnivesky JP (2012) Beliefs and attitudes about lung cancer screening among smokers. Lung Cancer 77(3):526–531CrossRef
24.
Zurück zum Zitat Lewis JA et al (2015) Low-dose CT lung cancer screening practices and attitudes among primary care providers at an academic medical center. Cancer Epidemiol Biomarkers Prev 24(4):664–670CrossRef Lewis JA et al (2015) Low-dose CT lung cancer screening practices and attitudes among primary care providers at an academic medical center. Cancer Epidemiol Biomarkers Prev 24(4):664–670CrossRef
25.
Zurück zum Zitat Rajupet S, Doshi D, Wisnivesky JP, Lin JJ (2017) Attitudes about lung cancer screening: primary care providers versus specialists. Clin Lung Cancer 18(6):e417–e423CrossRef Rajupet S, Doshi D, Wisnivesky JP, Lin JJ (2017) Attitudes about lung cancer screening: primary care providers versus specialists. Clin Lung Cancer 18(6):e417–e423CrossRef
26.
Zurück zum Zitat Klabunde CN, Marcus PM, Han PK, Richards TB, Vernon SW, Yuan G, Silvestri GA (2012) Lung cancer screening practices of primary care physicians: results from a national survey. Ann Fam Med 10(2):102–110CrossRef Klabunde CN, Marcus PM, Han PK, Richards TB, Vernon SW, Yuan G, Silvestri GA (2012) Lung cancer screening practices of primary care physicians: results from a national survey. Ann Fam Med 10(2):102–110CrossRef
27.
Zurück zum Zitat Kanodra NM, Pope C, Halbert CH, Silvestri GA, Rice LJ, Tanner NT (2016) Primary care provider and patient perspectives on lung cancer screening. A qualitative study. Ann Am Thorac Soc 13(11):1977–1982CrossRef Kanodra NM, Pope C, Halbert CH, Silvestri GA, Rice LJ, Tanner NT (2016) Primary care provider and patient perspectives on lung cancer screening. A qualitative study. Ann Am Thorac Soc 13(11):1977–1982CrossRef
28.
Zurück zum Zitat Tong EK, Strouse R, Hall J, Kovac M, Schroeder SA (2010) National survey of U.S. health professionals' smoking prevalence, cessation practices, and beliefs. Nicotine Tob Res 12(7):724–733CrossRef Tong EK, Strouse R, Hall J, Kovac M, Schroeder SA (2010) National survey of U.S. health professionals' smoking prevalence, cessation practices, and beliefs. Nicotine Tob Res 12(7):724–733CrossRef
29.
Zurück zum Zitat Warren GW, Dibaj S, Hutson A, Cummings KM, Dresler C, Marshall JR (2015) Identifying targeted strategies to improve smoking cessation support for cancer patients. J Thorac Oncol 10(11):1532–1537CrossRef Warren GW, Dibaj S, Hutson A, Cummings KM, Dresler C, Marshall JR (2015) Identifying targeted strategies to improve smoking cessation support for cancer patients. J Thorac Oncol 10(11):1532–1537CrossRef
30.
Zurück zum Zitat Himelhoch S, Riddle J, Goldman HH (2014) Barriers to implementing evidence-based smoking cessation practices in nine community mental health sites. Psychiatr Serv 65(1):75–80CrossRef Himelhoch S, Riddle J, Goldman HH (2014) Barriers to implementing evidence-based smoking cessation practices in nine community mental health sites. Psychiatr Serv 65(1):75–80CrossRef
31.
Zurück zum Zitat Jamal A, Phillips E, Gentzke AS, Homa DM, Babb SD, King BA, Neff LJ (2018) Current cigarette smoking among adults - United States, 2016. MMWR Morb Mortal Wkly Rep 67(2):53–59CrossRef Jamal A, Phillips E, Gentzke AS, Homa DM, Babb SD, King BA, Neff LJ (2018) Current cigarette smoking among adults - United States, 2016. MMWR Morb Mortal Wkly Rep 67(2):53–59CrossRef
32.
Zurück zum Zitat Leventhal AM, Bello MS, Galstyan E, Higgins ST, Barrington-Trimis JL. Association of Cumulative Socioeconomic and Health-Related Disadvantage With Disparities in Smoking Prevalence in the United States, 2008 to 2017. JAMA Intern Med. 2019;179(6):777–785. Leventhal AM, Bello MS, Galstyan E, Higgins ST, Barrington-Trimis JL. Association of Cumulative Socioeconomic and Health-Related Disadvantage With Disparities in Smoking Prevalence in the United States, 2008 to 2017. JAMA Intern Med. 2019;179(6):777–785. 
33.
Zurück zum Zitat Goodwin JS, Nishi S, Zhou J, Kuo YF. Use of the Shared Decision-Making Visit for Lung Cancer Screening Among Medicare Enrollees. JAMA Intern Med. 2019;179(5):716–718. Goodwin JS, Nishi S, Zhou J, Kuo YF. Use of the Shared Decision-Making Visit for Lung Cancer Screening Among Medicare Enrollees. JAMA Intern Med. 2019;179(5):716–718.
Metadaten
Titel
Healthcare Access, Utilization, and Preventive Health Behaviors by Eligibility for Lung Cancer Screening
verfasst von
Eric A. Miller
Paul F. Pinsky
Publikationsdatum
26.10.2019
Verlag
Springer US
Erschienen in
Journal of Cancer Education / Ausgabe 2/2021
Print ISSN: 0885-8195
Elektronische ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-019-01634-y

Weitere Artikel der Ausgabe 2/2021

Journal of Cancer Education 2/2021 Zur Ausgabe

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.